Open access
Open access
Powered by Google Translator Translator

Pharmacology/Pharmaceutical Industry

Review: The Use of Medication in Pregnancy

14 Jan, 2020 | 00:09h | UTC

The Use of Medication in Pregnancy – Deutsches Ärzteblatt international (free)

 


[Abstract Only] Randomized Trial: Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

14 Jan, 2020 | 00:03h | UTC

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes – New England Journal of Medicine (link to abstract – $ for full-text)

 


Randomized Trial: A Head-to-head Comparison of the Efficacy and Safety of Ixekizumab and Adalimumab in Biological-naïve Patients with Active Psoriatic Arthritis

14 Jan, 2020 | 00:02h | UTC

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial – Annals of Rheumatic Diseases (free)

Commentary: We Have a Winner: Head-to-Head Study Compares Biologics for PsA – MedPage Today (free registration required)

 


Study: Rifampicin is Likely to be the Safest Latent Tuberculosis Infection Treatment Option

12 Jan, 2020 | 21:26h | UTC

Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials – The Lancet Infectious Diseases (free registration required)

Commentaries: What is the best regimen to treat latent tuberculosis infection? – The Lancet Infectious Diseases (free) AND Four Months of Rifampicin May Be Best Option for Latent TB – Medscape / Reuters (free registration required)

 

Related Commentary on Twitter

 


Systematic Review and Economic Evaluation: Different Strategies for Pharmacological Thromboprophylaxis for Lower-limb Immobilization after Injury

12 Jan, 2020 | 21:14h | UTC

Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation – Health Technology Assessment (free)

Source: EvidenceAlerts

 


Meta-analysis: Systemic Pharmacological Treatments for Chronic Plaque Psoriasis

12 Jan, 2020 | 20:52h | UTC

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis – Cochrane Library (free)

Summary: Systemic (oral or injected) medicines for psoriasis – Cochrane Library (free)

Author Interview: Living Systematic Review: Pharmacological treatments for psoriasis, network meta analysis – Cochrane Library (free)

 


Study Commentary: Herpes Zoster Vaccine Reduces Chances of Shingles after Stem Cell Transplants

9 Jan, 2020 | 23:22h | UTC

Herpes zoster vaccine reduces chances of shingles after stem cell transplants – NIHR Signal (free)

Original Study: Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

 


Study Commentary: Continuing an Anticoagulant at Home After Abdominal Surgery Cuts Thrombosis Risk

9 Jan, 2020 | 23:21h | UTC

Continuing an anticoagulant at home after abdominal surgery cuts thrombosis risk – NIHR Signal (free)

Original Study: Systematic Review: Prolonged Thromboprophylaxis with Low Molecular Weight Heparin for Abdominal or Pelvic Surgery – Cochrane Library (link to study and summary)

 


Study Commentary: Taking Blood Pressure Medications at Night Seems Best

9 Jan, 2020 | 23:24h | UTC

Taking blood pressure medications at night seems best – NIHR Signal (free)

Original Study: Practice Changing? – Bedtime Hypertension Treatment Improves Cardiovascular Risk Reduction in Randomized Trial – European Heart Journal (free study and commentaries)

 


Study Commentary: ‘As-needed’ Combination Asthma Inhalers Can be More Effective than Regular Inhaled Steroids

9 Jan, 2020 | 23:12h | UTC

‘As-needed’ combination asthma inhalers can be more effective than regular inhaled steroids – NIHR Signal (free)

Original Study: Randomized Trial: In Adults with Mild to Moderate Asthma, As-Needed Long-acting Beta-agonist Plus an Inhaled Corticosteroid is as Effective as Maintenance Inhaled Corticosteroid Therapy Plus As-needed Short-acting Beta-agonist – The Lancet (link to abstract and commentary)

 


Review – Beyond Depression: Other Uses for Tricyclic Antidepressants

9 Jan, 2020 | 01:21h | UTC

Beyond depression: Other uses for tricyclic antidepressants – Cleveland Clinic Journal of Medicine (free)

 


Consensus Report: Framing Opioid Prescribing Guidelines for Acute Pain

8 Jan, 2020 | 22:22h | UTC

Framing Opioid Prescribing Guidelines for Acute Pain – National Academies of Sciences, Engineering, and Medicine (free PDF)

Commentaries: Statement on National Academies of Sciences, Engineering, and Medicine report on framing opioid prescribing guidelines for acute pain – U.S Food & Drug Administration (free) AND National Academies outlines opioid guidelines, aiming to make approach to prescribing more consistent – STAT (free)

 


[Abstract Only] Randomized Trial: Olanzapine Plus Standard Antiemetic Therapy for the Prevention of Chemotherapy-induced Nausea and Vomiting

8 Jan, 2020 | 22:12h | UTC

Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

 

Related Commentary on Twitter

 


[Abstract Only] Randomized Trial: Four Cycles of R-CHOP Non-inferior to Six Cycles of R-CHOP in Patients with Aggressive B-cell non-Hodgkin Lymphoma and Favorable Prognosis

8 Jan, 2020 | 21:49h | UTC

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial – The Lancet (link to abstract – $ for full-text)

 

Related Commentary on Twitter

 


[Abstract Only] Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia

8 Jan, 2020 | 21:51h | UTC

Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia – American Journal of Psychiatry (link to abstract – $ for full-text)

 


Randomized Trial: Long-term Aromatase Inhibitor Prevents Breast Cancer in High-risk Postmenopausal Women

8 Jan, 2020 | 21:48h | UTC

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial – The Lancet (free)

Commentaries: IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women – Queen Mary, University of London (free) AND Drug that prevents half of breast cancers carries on working – BBC (free) AND Long-Term Results of IBIS-II: Anastrozole for Breast Cancer Prevention – The ASCO Post (free)

 


[Abstract Only] Randomized Trial: Overall Survival with Daratumumab, Bortezomib, Melphalan, and Prednisone in Newly Diagnosed Multiple Myeloma

8 Jan, 2020 | 21:47h | UTC

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial – The Lancet (link to abstract – $ for full-text)

Commentary: Overall Survival With the Addition of Daratumumab to VMP in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma -The ASCO Post (free)

 


ACP Guideline: Testosterone Treatment in Adult Men With Age-Related Low Testosterone

8 Jan, 2020 | 08:51h | UTC

Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine (free)

Commentaries: ACP issues guideline on testosterone treatment for age-related low testosterone levels – ACP Internist (free) AND Most older men don’t need testosterone replacement, new guidelines say – Reuters (free)

 


Randomized Trial: Switching to Dolutegravir/Lamivudine Two-Drug Regimen Noninferior to Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1

8 Jan, 2020 | 08:37h | UTC

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose Two-Drug Regimen Versus Continuing a Tenofovir Alafenamide–Based Three- or Four-Drug Regimen for Maintenance of Virologic Suppression in Adults With HIV-1: Phase 3, Randomized, Non-inferiority TANGO Study – Clinical Infectious Diseases (free PDF)

 


FDA Safety Communication: Gabapentinoids may Cause Serious Respiratory Problems in Predisposed Patients

8 Jan, 2020 | 01:10h | UTC

FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) – U.S Food & Drug Administration (free)

See also: Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication – Serious Breathing Problems – U.S Food & Drug Administration (free)

Commentaries: Gabapentinoids Linked to Respiratory Problems in Certain Patients – NEJM Journal Watch (free) AND FDA warns gabapentin, pregabalin may cause serious breathing problems – The Hospitalist (free)

 


[Abstract Only] Randomized Trial: Direct Oral Anticoagulant Similarly Effective as Standard Anticoagulants for the Treatment of Acute Venous Thromboembolism in Children

8 Jan, 2020 | 01:02h | UTC

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial – The Lancet Haematology (link to abstract – $ for full-text)

Commentary: Thrombosis: Anticoagulant Rivaroxaban soon also available for children – Medical University of Vienna (free)

 


Consensus Statement: Insufficient Evidence to Recommend Brain Health Supplements

8 Jan, 2020 | 00:57h | UTC

The Real Deal on Brain Health Supplements: GCBH Recommendations on Vitamins, Minerals, and Other Dietary Supplements – Global Council and Brain Health (free)

Commentary: AARP report: Insufficient evidence that dietary supplements benefit brain health – Science-Based Medicine (free)

 


Meta-Analysis: Comparative Effects of 18 Antipsychotics on Metabolic Function in Patients with Schizophrenia

8 Jan, 2020 | 00:56h | UTC

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis – The Lancet Psychiatry (free)

Commentaries: Insights into metabolic dysregulations associated with antipsychotics – The Lancet Psychiatry (free) AND Not all antipsychotics increase the risk of diabetes and raise cholesterol – some may be protective – The Conversation (free)

 


[Abstract Only] Study: Long-term Follow Up of Gene Therapy for Hemophilia A

8 Jan, 2020 | 00:52h | UTC

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Study shows safety, long-term beneficial impact of gene therapy for patients with Hemophilia A – Queen Mary University of London (free)

 


[Abstract Only] Randomized Trial: Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

8 Jan, 2020 | 00:51h | UTC

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer – New England Journal of Medicine (free)

Commentaries: SABCS 2019: Adding Tucatinib to Capecitabine/Trastuzumab Improved Survival for Patients With Advanced HER2-Positive Breast Cancer – The ASCO Post (free) AND HER2CLIMB and DESTINY-Breast01 Findings in Heavily Pretreated HER2-positive MBC – ESMO (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.